Literature DB >> 15170632

Immunoglobulin GM and KM genotypes in hepatitis C virus infection.

Sasijit Vejbaesya1, Taweesak Tanwandee, Janardan P Pandey.   

Abstract

Hepatitis C virus (HCV) is a major health problem, affecting over 170 million people worldwide. HCV causes a wide spectrum of liver disease, varying from persistent to asymptomatic infection. To evaluate the role of immunoglobulin (Ig) GM and KM genes in HCV infection, 191 HCV-infected Thai subjects were studied. These included 43 individuals with transient HCV infection and 148 individuals with persistent chronic HCV infection. The controls consisted of 134 healthy individuals. Several GM and KM alleles were determined by polymerase chain reaction-based methods. The frequency of G1M(f) homozygotes was lower (52.4% vs. 64.2%, P = 0.03) and the frequency of G1M(z) homozygotes was higher (10.5% vs. 3.7%, P = 0.02) in patients than the respective frequencies in controls. These results suggest that GM genotypes make a significant contribution to the risk of acquiring HCV infection. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15170632     DOI: 10.1002/jmv.20102

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Interactive effects of immunoglobulin gamma and human leucocyte antigen genotypes on clearance and persistence of infection with hepatitis C virus.

Authors:  J P Pandey; M A Montes-Cano; J Aguilar-Reina; M F Gonzalez-Escribano
Journal:  Clin Exp Immunol       Date:  2007-10-09       Impact factor: 4.330

2.  Immunoglobulin allotypes influence IgG antibody responses to hepatitis C virus envelope proteins E1 and E2.

Authors:  Janardan P Pandey; Yuqun Luo; Robert C Elston; Yuping Wu; Frances Hite Philp; Jacquie Astemborski; David L Thomas; Dale M Netski
Journal:  Hum Immunol       Date:  2008-03-10       Impact factor: 2.850

Review 3.  Immunoglobulin GM Genes, Cytomegalovirus Immunoevasion, and the Risk of Glioma, Neuroblastoma, and Breast Cancer.

Authors:  Janardan P Pandey
Journal:  Front Oncol       Date:  2014-08-29       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.